Home > Insider Trading > Filing (0001225208-14-004987)

Filing Details

Accession Number:: 0001225208-14-004987
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-18 19:54:58
Reporting Period:: 2014-02-13

Filing Date:: 2014-02-18
Accepted Time:: 2014-02-18 19:54:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204663	H John Weiland	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-13	1,963	$86.15	119,672	No	4	M	Direct
Common Stock	Disposition	2014-02-13	1,483	$136.80	118,189	No	4	F	Direct
Common Stock	Disposition	2014-02-13	1,963	$138.01	116,226	No	4	S	Direct
Common Stock	Acquisiton	2014-02-14	69,893	$86.15	186,119	No	4	M	Direct
Common Stock	Disposition	2014-02-14	12,218	$139.12	173,901	No	4	S	Direct
Common Stock	Disposition	2014-02-14	59,205	$138.60	114,696	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2014-02-13	1,963	$0.00	1,963	$86.15
Common Stock	Option (Right to Buy)	Disposition	2014-02-14	69,893	$0.00	69,893	$86.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
69,893		2020-12-08	No	4	M	Direct
0		2020-12-08	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,599	Indirect	401(k) Plan

Footnotes

Exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Reflects a reduction by 9,489 shares to adjust for prior overstatements in previously filed Form 4s.
Shares withheld to pay taxes upon vesting of restricted stock granted under the Company's 2003 Long Term Incentive Plan.
Represents the weighted average sales price for price increments ranging from $138.01 to $138.02. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $139.08 to $139.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $138.08 to $139.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options fully vested and are currently exercisable.